ARCH THERAPEUTICS, INC.: 10-Q filed 2014-05-15
What ARCH THERAPEUTICS, INC. reported in its quarterly report filed 2014-05-15 (fiscal Q2 2014): 28 published measures, 91 facts as tagged in accession 0001144204-14-031168.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-05-15
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001144204-14-031168 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARCH THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 2,672,586 | USD | |
| At 2013-09-30 | 1,587,332 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 11,161,158 | USD | |
| At 2013-09-30 | 1,400,316 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | -8,488,572 | USD | |
| At 2013-09-30 | 187,016 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 2,631,285 | USD | |
| At 2013-09-30 | 557,319 | USD | |
| At 2013-03-31 | 881 | USD | |
| At 2012-09-30 | 17,139 | USD | |
| At 2006-03-05 | 0 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -8,380,156 | USD | 90 |
| 2013-10-01 to 2014-03-31 | -9,188,596 | USD | 182 |
| 2006-03-06 to 2014-03-31 | -13,820,467 | USD | 2948 |
| 2013-01-01 to 2013-03-31 | -172,676 | USD | 90 |
| 2012-10-01 to 2013-03-31 | -377,893 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-10-01 to 2014-03-31 | -1,641,437 | USD | 182 |
| 2006-03-06 to 2014-03-31 | -5,050,065 | USD | 2948 |
| 2012-10-01 to 2013-03-31 | -266,258 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-10-01 to 2014-03-31 | 0 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 19,053 | USD | 2948 |
| 2012-10-01 to 2013-03-31 | 0 | USD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 0 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 0 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 431,461 | USD | 2948 |
| 2013-01-01 to 2013-03-31 | 0 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 0 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-10-01 to 2014-03-31 | 3,715,403 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 7,700,403 | USD | 2948 |
| 2012-10-01 to 2013-03-31 | 250,000 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-10-01 to 2014-03-31 | 0 | USD | 182 |
| 2006-03-06 to 2014-03-31 | -19,053 | USD | 2948 |
| 2012-10-01 to 2013-03-31 | 0 | USD | 182 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 67,344,404 | shares | 90 |
| 2013-10-01 to 2014-03-31 | 63,744,820 | shares | 182 |
| 2013-01-01 to 2013-03-31 | 5,645,212 | shares | 90 |
| 2012-10-01 to 2013-03-31 | 5,645,212 | shares | 182 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -0.12 | USD/shares | 90 |
| 2013-10-01 to 2014-03-31 | -0.14 | USD/shares | 182 |
| 2013-01-01 to 2013-03-31 | -0.03 | USD/shares | 90 |
| 2012-10-01 to 2013-03-31 | -0.07 | USD/shares | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 322 | USD | |
| At 2013-09-30 | 322 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-10-01 to 2014-03-31 | 503,355 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 791,282 | USD | 2948 |
| 2012-10-01 to 2013-03-31 | 0 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -1,295,573 | USD | 90 |
| 2013-10-01 to 2014-03-31 | -2,076,248 | USD | 182 |
| 2006-03-06 to 2014-03-31 | -6,173,502 | USD | 2948 |
| 2013-01-01 to 2013-03-31 | -126,889 | USD | 90 |
| 2012-10-01 to 2013-03-31 | -289,701 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 2,662,202 | USD | |
| At 2013-09-30 | 1,576,948 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 27,765 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 55,530 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 644,124 | USD | 2948 |
| 2013-01-01 to 2013-03-31 | 45,804 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 88,212 | USD | 182 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 4,368,876 | USD | |
| At 2013-09-30 | 455,609 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 104,155 | USD | |
| At 2013-09-30 | 314,769 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 1,295,573 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 2,076,248 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 6,604,963 | USD | 2948 |
| 2013-01-01 to 2013-03-31 | 126,889 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 289,701 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 487,090 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 630,756 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 1,610,996 | USD | 2948 |
| 2013-01-01 to 2013-03-31 | 9,240 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 11,290 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 71,926,487 | shares | |
| At 2013-09-30 | 60,145,237 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 5,259,969 | USD | |
| At 2013-09-30 | 4,758,742 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 10,062 | USD | |
| At 2013-09-30 | 10,062 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 30,917 | USD | |
| At 2013-09-30 | 19,629 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 808,483 | USD | 90 |
| 2013-10-01 to 2014-03-31 | 1,445,492 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 4,993,967 | USD | 2948 |
| 2013-01-01 to 2013-03-31 | 117,649 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 278,411 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-10-01 to 2014-03-31 | 0 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 18,371 | USD | 2948 |
| 2012-10-01 to 2013-03-31 | 847 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-10-01 to 2014-03-31 | -210,614 | USD | 182 |
| 2006-03-06 to 2014-03-31 | 104,155 | USD | 2948 |
| 2012-10-01 to 2013-03-31 | 45,038 | USD | 182 |
Inspect the source
- Entity
- ARCH THERAPEUTICS, INC. / CIK 0001537561
- Captured
- SEC response SHA-256
63d0e84748ee59ab7c6817be68d0a32b23d83273213bc50081bb86253a1d4cc2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001537561.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))